CORMEDIX INC. (CRMD) Free cash flow 2016–2025
CORMEDIX INC. (CRMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$172.8MFY2025 · since FY2016: -$22.3M → $172.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $172.8M | +440.6% |
| FY2024 | -$50.7M | -31.0% |
| FY2023 | -$38.7M | -57.6% |
| FY2022 | -$24.6M | -8.8% |
| FY2021 | -$22.6M | -2.3% |
| FY2020 | -$22.1M | -46.3% |
| FY2019 | -$15.1M | +36.5% |
| FY2018 | -$23.7M | +17.4% |
| FY2017 | -$28.7M | -28.7% |
| FY2016 | -$22.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRMD financial trends
CRMD RevenueCRMD Net incomeCRMD Net marginCRMD Gross profitCRMD Gross marginCRMD Operating incomeCRMD Operating marginCRMD Operating cash flowCRMD Capital expendituresCRMD Return on equityCRMD Stock buybacksCRMD Dividends paidCRMD Total assetsCRMD Total liabilitiesCRMD Shareholders’ equityCRMD overview →